Technical Analysis for SRNE - Sorrento Therapeutics, Inc.

Grade Last Price % Change Price Change
F 6.745 2.51% 0.17
SRNE closed down 5.73 percent on Wednesday, May 12, 2021, on 75 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical SRNE trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 2.51%
Inside Day Range Contraction 2.51%
Wide Bands Range Expansion 2.51%
Oversold Stochastic Weakness 2.51%
Stochastic Buy Signal Bullish -3.37%
Pocket Pivot Bullish Swing Setup -3.37%
Lower Bollinger Band Touch Weakness -3.37%
Oversold Stochastic Weakness -3.37%
Oversold Stochastic Weakness -0.44%
NR7 Range Contraction -6.32%
Older End-of-Day Signals for SRNE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 3% about 1 hour ago
Up 2% about 1 hour ago
Up 1% about 1 hour ago
Down 3% about 20 hours ago
Possible Inside Day about 21 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sorrento Therapeutics, Inc. Description

Sorrento Therapeutics, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel and proprietary biotherapeutics for the treatment of cancer, inflammation, metabolic, and infectious diseases in the United States. The company's G-MAB, a human antibody library platform, facilitates the rapid identification and isolation of highly specific antibody therapeutic product candidates that bind to disease targets appropriate for antibody therapy. Its human antibody library technology is used to construct large human antibody libraries. It has license agreement with OPKO Health, Inc. to develop, manufacture, use, market, sell, offer to sell, import, and export certain products related to the development, manufacture, marketing, and sale of drugs for ophthalmological indications. Sorrento Therapeutics, Inc. is based in San Diego, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Biology Immunology Immune System Infectious Diseases Disease Treatment Of Cancer Monoclonal Antibody Inflammation Antibody Therapeutic Product Library Opko Health Antibody Therapy

Is SRNE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.39
52 Week Low 3.82
Average Volume 8,488,023
200-Day Moving Average 9.15
50-Day Moving Average 8.29
20-Day Moving Average 7.63
10-Day Moving Average 7.38
Average True Range 0.56
ADX 18.73
+DI 15.68
-DI 29.12
Chandelier Exit (Long, 3 ATRs ) 7.40
Chandelier Exit (Short, 3 ATRs ) 8.02
Upper Bollinger Band 8.83
Lower Bollinger Band 6.42
Percent B (%b) 0.07
BandWidth 31.67
MACD Line -0.41
MACD Signal Line -0.33
MACD Histogram -0.0793
Fundamentals Value
Market Cap 1.73 Billion
Num Shares 263 Million
EPS -2.40
Price-to-Earnings (P/E) Ratio -2.74
Price-to-Sales 40.11
Price-to-Book 10.20
PEG Ratio -0.07
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.26
Resistance 3 (R3) 7.32 7.16 7.14
Resistance 2 (R2) 7.16 6.99 7.13 7.10
Resistance 1 (R1) 6.87 6.89 6.79 6.81 7.07
Pivot Point 6.71 6.71 6.67 6.68 6.71
Support 1 (S1) 6.42 6.54 6.34 6.36 6.09
Support 2 (S2) 6.26 6.44 6.23 6.06
Support 3 (S3) 5.97 6.26 6.02
Support 4 (S4) 5.91